Global mAb Biosimilar Market Research Report 2016

mAbバイオシミラーの世界市場2016

◆タイトル:Global mAb Biosimilar Market Research Report 2016
◆商品コード:QYR61221888
◆調査・発行会社:QYResearch
◆発行日:2016年10月5日
◆ページ数:113
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD2,900 ⇒換算¥319,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD5,800 ⇒換算¥638,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

※当調査レポートでは、mAbバイオシミラーの世界市場について調査・分析し、市場概観、市場動向、mAbバイオシミラーの世界市場規模、市場予測、地域別市場規模(日本市場、中国市場、米国市場、欧州市場など)、用途別市場分析、製造コスト分析、主要なメーカー分析(企業概要、主な製品概要、生産・販売動向、連絡先など)、種類別価格分析、価格情報、市場環境分析、輸出・輸入データ、市場シェア分析などを含め、以下の構成でお届けいたします。

・mAbバイオシミラーの世界市場:市場概要
・mAbバイオシミラーの世界市場:市場動向
・mAbバイオシミラーの世界市場:市場規模、市場規模予測
・mAbバイオシミラーの地域別市場規模(日本市場、中国市場、アメリカ市場、ヨーロッパ市場など)
・mAbバイオシミラーの世界市場:用途別市場分析
・mAbバイオシミラーの製造コスト分析
・mAbバイオシミラーの企業間競争状況
・mAbバイオシミラーの主要なメーカー分析(企業情報、主な製品概要、生産・販売動向、連絡先など)
・mAbバイオシミラーの種類別価格分析
・mAbバイオシミラーの価格動向
・mAbバイオシミラーの世界市場:市場環境分析
・mAbバイオシミラーの世界市場:輸出・輸入データ
・mAbバイオシミラーの世界市場:市場シェア分析
・mAbバイオシミラーの世界市場:結論
...

Notes:
Production, means the output of mAb Biosimilar

Revenue, means the sales value of mAb Biosimilar

This report studies mAb Biosimilar in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

Baxter

GSK

Merck

Novartis

Pfizer

Roche Holding

Sanofi

Mitsubishi Tanabe Pharma

Hospira

Alvartis Pharma

Allergan

Amega Biotech

Biogen

LG Lifesciences

Samsung Biologics

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of mAb Biosimilar in these regions, from 2011 to 2021 (forecast), like

North America

Europe

China

Japan

Southeast Asia

India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by application, this report focuses on consumption, market share and growth rate of mAb Biosimilar in each application, can be divided into

Application 1

Application 2

Application 3

【レポートの目次】

Table of Contents

Global mAb Biosimilar Market Research Report 2016

1 mAb Biosimilar Market Overview

1.1 Product Overview and Scope of mAb Biosimilar

1.2 mAb Biosimilar Segment by Type

1.2.1 Global Production Market Share of mAb Biosimilar by Type in 2015

1.2.2 Type I

1.2.3 Type II

1.2.4 Type III

1.3 mAb Biosimilar Segment by Application

1.3.1 mAb Biosimilar Consumption Market Share by Application in 2015

1.3.2 Application 1

1.3.3 Application 2

1.3.4 Application 3

1.4 mAb Biosimilar Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of mAb Biosimilar (2011-2021)

2 Global mAb Biosimilar Market Competition by Manufacturers

2.1 Global mAb Biosimilar Production and Share by Manufacturers (2015 and 2016)

2.2 Global mAb Biosimilar Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global mAb Biosimilar Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers mAb Biosimilar Manufacturing Base Distribution, Sales Area and Product Type

2.5 mAb Biosimilar Market Competitive Situation and Trends

2.5.1 mAb Biosimilar Market Concentration Rate

2.5.2 mAb Biosimilar Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global mAb Biosimilar Production, Revenue (Value) by Region (2011-2016)

3.1 Global mAb Biosimilar Production and Market Share by Region (2011-2016)

3.2 Global mAb Biosimilar Revenue (Value) and Market Share by Region (2011-2016)

3.3 Global mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

3.4 North America mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

3.5 Europe mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

3.6 China mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

3.7 Japan mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Southeast Asia mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

3.9 India mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

4 Global mAb Biosimilar Supply (Production), Consumption, Export, Import by Regions (2011-2016)

4.1 Global mAb Biosimilar Consumption by Regions (2011-2016)

4.2 North America mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India mAb Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)

5 Global mAb Biosimilar Production, Revenue (Value), Price Trend by Type

5.1 Global mAb Biosimilar Production and Market Share by Type (2011-2016)

5.2 Global mAb Biosimilar Revenue and Market Share by Type (2011-2016)

5.3 Global mAb Biosimilar Price by Type (2011-2016)

5.4 Global mAb Biosimilar Production Growth by Type (2011-2016)

6 Global mAb Biosimilar Market Analysis by Application

6.1 Global mAb Biosimilar Consumption and Market Share by Application (2011-2016)

6.2 Global mAb Biosimilar Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global mAb Biosimilar Manufacturers Profiles/Analysis

7.1 Baxter

7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

7.1.2 mAb Biosimilar Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 Baxter mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)

7.1.4 Main Business/Business Overview

7.2 GSK

7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

7.2.2 mAb Biosimilar Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 GSK mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)

7.2.4 Main Business/Business Overview

7.3 Merck

7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

7.3.2 mAb Biosimilar Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Merck mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)

7.3.4 Main Business/Business Overview

7.4 Novartis

7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

7.4.2 mAb Biosimilar Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 Novartis mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)

7.4.4 Main Business/Business Overview

7.5 Pfizer

7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

7.5.2 mAb Biosimilar Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 Pfizer mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)

7.5.4 Main Business/Business Overview

7.6 Roche Holding

7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

7.6.2 mAb Biosimilar Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 Roche Holding mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)

7.6.4 Main Business/Business Overview

7.7 Sanofi

7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

7.7.2 mAb Biosimilar Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 Sanofi mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)

7.7.4 Main Business/Business Overview

7.8 Mitsubishi Tanabe Pharma

7.8.1 Company Basic Information, Manufacturing Base and Its Competitors

7.8.2 mAb Biosimilar Product Type, Application and Specification

7.8.2.1 Type I

7.8.2.2 Type II

7.8.3 Mitsubishi Tanabe Pharma mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)

7.8.4 Main Business/Business Overview

7.9 Hospira

7.9.1 Company Basic Information, Manufacturing Base and Its Competitors

7.9.2 mAb Biosimilar Product Type, Application and Specification

7.9.2.1 Type I

7.9.2.2 Type II

7.9.3 Hospira mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)

7.9.4 Main Business/Business Overview

7.10 Alvartis Pharma

7.10.1 Company Basic Information, Manufacturing Base and Its Competitors

7.10.2 mAb Biosimilar Product Type, Application and Specification

7.10.2.1 Type I

7.10.2.2 Type II

7.10.3 Alvartis Pharma mAb Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)

7.10.4 Main Business/Business Overview

7.11 Allergan

7.12 Amega Biotech

7.13 Biogen

7.14 LG Lifesciences

7.15 Samsung Biologics

8 mAb Biosimilar Manufacturing Cost Analysis

8.1 mAb Biosimilar Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of mAb Biosimilar

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 mAb Biosimilar Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of mAb Biosimilar Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global mAb Biosimilar Market Forecast (2016-2021)

12.1 Global mAb Biosimilar Production, Revenue Forecast (2016-2021)

12.2 Global mAb Biosimilar Production, Consumption Forecast by Regions (2016-2021)

12.3 Global mAb Biosimilar Production Forecast by Type (2016-2021)

12.4 Global mAb Biosimilar Consumption Forecast by Application (2016-2021)

12.5 mAb Biosimilar Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List of Tables and Figures



Figure Picture of mAb Biosimilar

Figure Global Production Market Share of mAb Biosimilar by Type in 2015

Figure Product Picture of Type I

Table Major Manufacturers of Type I

Figure Product Picture of Type II

Table Major Manufacturers of Type II

Figure Product Picture of Type III

Table Major Manufacturers of Type III

Table mAb Biosimilar Consumption Market Share by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Application 3 Examples

Figure North America mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)

Figure Europe mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)

Figure China mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)

Figure Japan mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)

Figure Southeast Asia mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)

Figure India mAb Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)

Figure Global mAb Biosimilar Revenue (Million UDS) and Growth Rate (2011-2021)

Table Global mAb Biosimilar Production of Key Manufacturers (2015 and 2016)

Table Global mAb Biosimilar Production Share by Manufacturers (2015 and 2016)

Figure 2015 mAb Biosimilar Production Share by Manufacturers

Figure 2016 mAb Biosimilar Production Share by Manufacturers

Table Global mAb Biosimilar Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global mAb Biosimilar Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global mAb Biosimilar Revenue Share by Manufacturers

Table 2016 Global mAb Biosimilar Revenue Share by Manufacturers

Table Global Market mAb Biosimilar Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market mAb Biosimilar Average Price of Key Manufacturers in 2015

Table Manufacturers mAb Biosimilar Manufacturing Base Distribution and Sales Area

Table Manufacturers mAb Biosimilar Product Type

Figure mAb Biosimilar Market Share of Top 3 Manufacturers

Figure mAb Biosimilar Market Share of Top 5 Manufacturers

Table Global mAb Biosimilar Production by Regions (2011-2016)

Figure Global mAb Biosimilar Production and Market Share by Regions (2011-2016)

Figure Global mAb Biosimilar Production Market Share by Regions (2011-2016)

Figure 2015 Global mAb Biosimilar Production Market Share by Regions

Table Global mAb Biosimilar Revenue by Regions (2011-2016)

Table Global mAb Biosimilar Revenue Market Share by Regions (2011-2016)

Table 2015 Global mAb Biosimilar Revenue Market Share by Regions

Table Global mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Table North America mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Table Europe mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Table China mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Table Japan mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Table Southeast Asia mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Table India mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Table Global mAb Biosimilar Consumption Market by Regions (2011-2016)

Table Global mAb Biosimilar Consumption Market Share by Regions (2011-2016)

Figure Global mAb Biosimilar Consumption Market Share by Regions (2011-2016)

Figure 2015 Global mAb Biosimilar Consumption Market Share by Regions

Table North America mAb Biosimilar Production, Consumption, Import & Export (2011-2016)

Table Europe mAb Biosimilar Production, Consumption, Import & Export (2011-2016)

Table China mAb Biosimilar Production, Consumption, Import & Export (2011-2016)

Table Japan mAb Biosimilar Production, Consumption, Import & Export (2011-2016)

Table Southeast Asia mAb Biosimilar Production, Consumption, Import & Export (2011-2016)

Table India mAb Biosimilar Production, Consumption, Import & Export (2011-2016)

Table Global mAb Biosimilar Production by Type (2011-2016)

Table Global mAb Biosimilar Production Share by Type (2011-2016)

Figure Production Market Share of mAb Biosimilar by Type (2011-2016)

Figure 2015 Production Market Share of mAb Biosimilar by Type

Table Global mAb Biosimilar Revenue by Type (2011-2016)

Table Global mAb Biosimilar Revenue Share by Type (2011-2016)

Figure Production Revenue Share of mAb Biosimilar by Type (2011-2016)

Figure 2015 Revenue Market Share of mAb Biosimilar by Type

Table Global mAb Biosimilar Price by Type (2011-2016)

Figure Global mAb Biosimilar Production Growth by Type (2011-2016)

Table Global mAb Biosimilar Consumption by Application (2011-2016)

Table Global mAb Biosimilar Consumption Market Share by Application (2011-2016)

Figure Global mAb Biosimilar Consumption Market Share by Application in 2015

Table Global mAb Biosimilar Consumption Growth Rate by Application (2011-2016)

Figure Global mAb Biosimilar Consumption Growth Rate by Application (2011-2016)

Table Baxter Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Baxter mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Figure Baxter mAb Biosimilar Market Share (2011-2016)

Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GSK mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Figure GSK mAb Biosimilar Market Share (2011-2016)

Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Merck mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Figure Merck mAb Biosimilar Market Share (2011-2016)

Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis mAb Biosimilar Market Share (2011-2016)

Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer mAb Biosimilar Market Share (2011-2016)

Table Roche Holding Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Roche Holding mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Figure Roche Holding mAb Biosimilar Market Share (2011-2016)

Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sanofi mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Figure Sanofi mAb Biosimilar Market Share (2011-2016)

Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Mitsubishi Tanabe Pharma mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Figure Mitsubishi Tanabe Pharma mAb Biosimilar Market Share (2011-2016)

Table Hospira Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Hospira mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Figure Hospira mAb Biosimilar Market Share (2011-2016)

Table Alvartis Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Alvartis Pharma mAb Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

Figure Alvartis Pharma mAb Biosimilar Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of mAb Biosimilar

Figure Manufacturing Process Analysis of mAb Biosimilar

Figure mAb Biosimilar Industrial Chain Analysis

Table Raw Materials Sources of mAb Biosimilar Major Manufacturers in 2015

Table Major Buyers of mAb Biosimilar

Table Distributors/Traders List

Figure Global mAb Biosimilar Production and Growth Rate Forecast (2016-2021)

Figure Global mAb Biosimilar Revenue and Growth Rate Forecast (2016-2021)

Table Global mAb Biosimilar Production Forecast by Regions (2016-2021)

Table Global mAb Biosimilar Consumption Forecast by Regions (2016-2021)

Table Global mAb Biosimilar Production Forecast by Type (2016-2021)

Table Global mAb Biosimilar Consumption Forecast by Application (2016-2021)



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[mAbバイオシミラーの世界市場2016] (Global mAb Biosimilar Market Research Report 2016 / QYR61221888)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆